Search

everythinglearnresearchcommunity

for

Search:↓

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Balding people may have higher heart disease risk.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Minoxidil helps hair regrowth in alopecia, but more research needed.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

Higher DHT in male baldness may protect against prostate cancer.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

Biotin supplements may help hair regrowth in alopecia areata patients with low biotinidase activity.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

TrichoScan needs optimization as it underestimated hair density by 38.9% compared to manual counting.

Patients with Alopecia Areata often have higher anxiety and depression.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Ellis van Creveld syndrome, a rare genetic disorder, can cause unexpected abnormalities in various body organs, requiring thorough patient evaluations.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

A young man was diagnosed with trichoepitheliomas, causing thick skin and hair loss.